OneMedNet Corporation (ONMDW) 주식 분석

회사 개요

OneMedNet Corporation (ONMDW) operates as a healthcare software provider that delivers digital medical image management, exchange, and sharing solutions across the Americas, Europe, and the Middle East. The company offers iRWD, a platform designed to supply regulatory-grade imaging and clinical data specifically for the pharmaceutical and device manufacturing sectors. The specific sector and industry classifications for this entity are currently listed as unavailable in the available data, which limits the ability to contextualize its position within broader market categories. Regarding scale, the company reports a market capitalization that is listed as unavailable, an annual revenue of $1.36M over the trailing twelve months, and an employee count that is not disclosed in the provided facts. These figures indicate that the company functions as a micro-cap entity with limited revenue generation, suggesting a niche operational footprint rather than a dominant market position in the healthcare technology landscape.

재무 건전성

The company reported a trailing twelve-month revenue of $1.36M, yet simultaneously posted a net income loss of $2,801,000 and an EBITDA of -$9,602,000. The substantial gap between the positive revenue figure and the significant negative net income reveals a highly inefficient cost structure where operating expenses and losses far exceed the income generated from sales. Free cash flow stands at -$7,840,750, indicating that the company is burning cash and lacks the current financial flexibility to fund operations or capital expenditures without external financing. The gross margin is reported at -37.0%, the operating margin at -345.9%, and the profit margin at -206.1%, all of which indicate severe unprofitability across every level of the income statement. In terms of liquidity, the company holds $585,000 in cash against $974,000 in debt, resulting in a debt-to-equity ratio that is listed as unavailable. The current ratio is 0.43, a figure that indicates the company's current assets are insufficient to cover its current liabilities, pointing to potential short-term liquidity risks. Furthermore, the return on equity is unavailable while the return on assets is -205.6%, metrics that reveal that management is effectively destroying value relative to the equity invested and the total assets employed.

밸류에이션 평가

The trailing P/E ratio and forward P/E ratio are both listed as unavailable, preventing a direct comparison of current versus expected earnings trajectory. The price-to-book ratio is -1.21, a negative valuation metric that indicates the market is pricing the company below its book value, often seen in firms with significant accumulated losses or negative tangible equity. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are also unavailable, which suggests that traditional multiple-based valuation models cannot be applied due to the lack of profitability and available market data. The 52-week high and 52-week low are both recorded at $0.07, meaning the stock is trading at 0% relative to this range as the current price equals the historical boundaries. The beta value is 1.17, which implies that the stock's price volatility is 17% higher than the broader market, suggesting greater sensitivity to market fluctuations than large-cap benchmarks.

Growth & Income

Revenue growth year-over-year is reported at an extraordinary 3326.9%, whereas earnings growth is listed as unavailable due to the persistent net losses. While revenue is expanding rapidly, the absence of earnings growth confirms that top-line expansion is not yet translating into bottom-line profitability, implying that the high revenue growth is driven by scale or specific transaction types rather than operational efficiency. The company does not pay dividends, as evidenced by the unavailable dividend yield and payout ratio, meaning it reinvests any remaining capital or raises new funds to sustain operations rather than returning value to shareholders. Consequently, the overall growth and income profile is characterized by aggressive revenue expansion paired with significant cash burn and a complete lack of dividend income or return on capital for investors.